TransBioLine - Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

The external pageTransBioLinecall_made project is funded by the innovative medicines initiative (IMI), pharmna companies and academic institutes team up to identify biomarkers to improve drug safety as well as diagnosis and management of diseases. In particular we will perform a comprehensive screening of micro-RNAs to identify biomarkers of tissue damage and define standardised tests for measuring these biomarkers